About UsPipelineTechnologyPartneringInvestor RelationsNewsCareers
  
   
 

Micromet develops novel antibody-based drugs for
              the treatment of cancer, inflammation and autoimmune diseases.

  
   
 
Upcoming Events

March 4, 2010:

Micromet to report fourth quarter and full year 2009 financial results on March 4

  see webcast

March 2, 2010:

Micromet to participate in 2010 RBC Capital Markets Healthcare Conference
Latest News
March 9th, 2010
Micromet Announces Proposed Public Offering of Common Stock
 more
March 4th, 2010
Micromet Reports Fourth Quarter and Full Year 2009 Financial Results
 more
Stock Quote
Exchange: NASDAQ Global Market
Ticker Symbol: MITI
Last Trade: $ 7.94
Change: $ -0.15
Date: Mar 10, 2010
Time: 2:29PM
(20 min delay)
 
   
ContactDirectionsEmail Alert 
HomeImprintLegal Notices